Aerie Pharmaceuticals
AERI
#6008
Rank
HK$5.85 B
Marketcap
HK$118.49
Share price
0.00%
Change (1 day)
82.80%
Change (1 year)

Revenue for Aerie Pharmaceuticals (AERI)

Revenue in 2022 (TTM): HK$1.67 Billion

According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is HK$1.66 Billion. In 2021 the company made a revenue of HK$1.51 Billion an increase over the revenue in the year 2020 that were of HK$0.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aerie Pharmaceuticals from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) HK$1.67 B10.49%
2021 HK$1.51 B134.88%
2020 HK$0.64 B18.41%
2019 HK$0.54 B187.44%
2018 HK$0.18 B
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$2.66 B 60.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$40.62 M-97.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$490.86 B 29,428.70%๐Ÿ‡บ๐Ÿ‡ธ USA